💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Cytokinetics, Incorporated (CYTK)
« Back to company indexCYTK Chatter Timeline
Stock Ticker for CYTK
Most Active Tweeters for CYTK
| User | Tweets |
|---|---|
| @TradeWithAlerts | 7 |
| @FlashAlert_me | 7 |
| @Tickeron | 6 |
| @quantisnow | 6 |
| @tazjam67 | 6 |
Recent Tweets for CYTK
 |
@Tickeron Cytokinetics Inc to report earnings on August 05, 2021. Earnings per share (EPS) estimate: $-0.66 $CYTK… https://t.co/dVXs2dkVtZ 1:08am |
 |
@TradeWithAlerts Large Print $CYTK Size: 148379 Price: 29.35 Time: 1208 Amount: $4,354,923.65 - Delayed - For real time prints subsc… https://t.co/n6kJydcbzU August 4th 2021, 4:08pm |
|
@TradeWithAlerts Large Print $CYTK Size: 224600 Price: 28.95 Time: 948 Amount: $6,502,170.00 - Delayed - For real time prints subscr… https://t.co/3Ajf6ttLPT August 4th 2021, 1:08pm |
|
@TradeWithAlerts Large Print $CYTK Size: 142700 Price: 28.6 Time: 1554 Amount: $4,081,220.00 - Delayed - For real time prints subscr… https://t.co/OgIYqY5BqQ August 3rd 2021, 7:08pm |
 |
@askwarrenbuffet $CYTK To Be Featured on "Your Money" Segment On CNN, Share Price To Rise On Nationwide Exposure… https://t.co/rdwPey6ieC August 3rd 2021, 2:08pm |
 |
@BigCForever One of the stock chased by retail.. with insider sells ... $cytk https://t.co/HMsCZFOOu0 August 3rd 2021, 12:08am |
 |
@InsiderForms $CYTK Insider Cragg David has Sold 2,616 Shares. Title :Chief HR; Admin Officer Total Cost: $77,616.72 Buy/Sell :… https://t.co/o4XIXKStGa August 2nd 2021, 11:08pm |
 |
@fintel_io Insider David Cragg reports selling 2,616 shares of $CYTK for a total cost of $77,616.72 https://t.co/a9Roym1DGj August 2nd 2021, 11:08pm |
 |
@EdgarInsider Filing for 8-K [Press/News Current Report] has been made with the SEC: $CYTK CYTOKINETICS INC https://t.co/kmvd2HlX1n August 2nd 2021, 8:08pm |
 |
@investor_feed $CYTK 8-K Cytokinetics (2 Aug, 4:00pm) ? Other Events; Financial Statements and Exhibits… https://t.co/EvRXfp4e8g August 2nd 2021, 8:08pm |
 |
@FlashAlert_me $CYTK [15s. delayed] filed form 8-K on August 02, 16:00:30 https://t.co/MlFnEVdQsF August 2nd 2021, 8:08pm |
|
@FlashAlert_me $CYTK [15s. delayed]: Issued Press Release on August 02, 16:00:00: Cytokinetics Announces Inducement Grants Under N… https://t.co/NUZYJuQjyM August 2nd 2021, 8:08pm |
 |
@quantisnow $CYTK ? Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/knhXaQOAyP 30s delayed. August 2nd 2021, 8:08pm |
 |
@deven_gilmore $CYTK I tried to short this on their news play. 100% increase in 1 day. Price has been stable for about two weeks n… https://t.co/3xtyhCFVkY August 2nd 2021, 4:08pm |
 |
@SmallCapsDaily $CYTK Cytokinetics Announces Start of COURAGE-ALS, a Phase 3 Clinical Trial of Reldesemtiv in Patients With Amyotro… https://t.co/Nw5yULYStB August 2nd 2021, 3:08pm |
 |
@MarcJacksonLA $CYTK Cytokinetics Announces Start of COURAGE-ALS, a Phase 3 Clinical Trial of Reldesemtiv in Patients With Amyotro… https://t.co/2hJwJv4EWg August 2nd 2021, 1:08pm |
 |
@Briefingcom $CYTK: Cytokinetics announces start of COURAGE-ALS, a phase 3 clinical trial of reldesemtiv in patients with... https://t.co/m43S5JFuMc August 2nd 2021, 1:08pm |
 |
@alsadvocacy $CYTK Or we could just call it the current Cytokinetics trial or even the Reldesemtiv trial ;-) (These cute trial n… https://t.co/K1FxtmT6tj August 2nd 2021, 12:08pm |
 |
@NedPagliarulo RT @bio_clouseau: $CYTK trying again in ALS with Reldesemtiv despite P2 failure. New P3 called COURAGE-ALS. Previous P2/P3 failures in FORT… August 2nd 2021, 12:08pm |
 |
@bio_clouseau $CYTK trying again in ALS with Reldesemtiv despite P2 failure. New P3 called COURAGE-ALS. Previous P2/P3 failures i… https://t.co/soDQAazZNb August 2nd 2021, 12:08pm |
 |
@tinhatoptimist RT @Sports_bios: Mentioned ALS as an area to watch in next couple of mos.. $CYTK Reldesemtiv prolly one of more promising candidate - "clo… August 2nd 2021, 12:08pm |
 |
@Sports_bios Mentioned ALS as an area to watch in next couple of mos.. $CYTK Reldesemtiv prolly one of more promising candidate… https://t.co/jGDU06EbbG August 2nd 2021, 12:08pm |
 |
@John_galt1111 $CYTK: Cytokinetics Announces Start of COURAGE-ALS, a Phase 3 Clinical Trial of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis August 2nd 2021, 12:08pm |
 |
@ethanFlare $CYTK - Cytokinetics opens enrollment for late-stage reldesemtiv ALS study Cap size: mid, Float 98.2%, Short Intere… https://t.co/uNOMyyKNlq August 2nd 2021, 11:08am |
|
@EdgarInsider A new filing Form 8-K [Press/News Current Report] has been made at the SEC by $CYTK CYTOKINETICS INC https://t.co/sg2YnBsm7k August 2nd 2021, 11:08am |
|
@quantisnow $CYTK ? Cytokinetics, Incorporated filed SEC Form 8-K: Other Events https://t.co/VTgIXEZDKg 30s delayed. August 2nd 2021, 11:08am |
|
@FlashAlert_me $CYTK [15s. delayed]: Issued Press Release on August 02, 07:30:00: Cytokinetics Announces Start of COURAGE-ALS, a P… https://t.co/ojWCiB35CT August 2nd 2021, 11:08am |
 |
@phasefivebot $CYTK Cytokinetics Announces Start Of Courage-Als, A Phase 3 Clinical Trial Of Reldesemtiv In Patients With Amyotro… https://t.co/HF2n0GyFl2 August 2nd 2021, 11:08am |
 |
@StockNewsBot2 $CYTK Cytokinetics Announces Start of COURAGE-ALS, a Phase 3 Clinical Trial of Reldesemtiv in Patients With Amyotro… https://t.co/NvkJyxZPlG August 2nd 2021, 11:08am |
 |
@CNEstocks ? $CYTK Cytokinetics Announces Start of COURAGE-ALS, a Phase 3 Clinical Trial of Reldesemtiv in Patients With Amy… https://t.co/sVaYpbPJpf August 2nd 2021, 11:08am |
|
@FlashAlert_me $CYTK [15s. delayed] filed form 8-K on August 02, 07:30:20: Item8.01: Other Material Events https://t.co/KxsfwObXRH August 2nd 2021, 11:08am |
 |
@mikalche $CYTK Cytokinetics Announces Start of COURAGE-ALS, a Phase 3 Clinical Trial of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis August 2nd 2021, 11:08am |
|
@quantisnow $CYTK ? Cytokinetics Announces Start of COURAGE-ALS, a Phase 3 Clinical Trial of Reldesemtiv in Patients With Amyot… https://t.co/1uhwABmZI6 August 2nd 2021, 11:08am |
 |
@stock_titan $CYTK Cytokinetics Announces Start of COURAGE-ALS, a Phase 3 Clinical Trial of Reldesemtiv in Patients With Amyotro… https://t.co/dGAmKhoqyn August 2nd 2021, 11:08am |
|
@Tickeron $CYTK enters an Uptrend because Momentum Indicator exceeded the 0 level on July 19, 2021. View odds for this and ot… https://t.co/7rkaWCccbG August 1st 2021, 10:08pm |
 |
@jc1odi The CEO of $CYTK is paid a lot, 6 million/year,2.9 times higher than the level predicted by the company’s performance. August 1st 2021, 3:08pm |
 |
@tradersreport RT @Tickeron: $CYTK enters an Uptrend as Momentum Indicator exceeded the 0 level on July 19, 2021. View odds for this and other indicators:… August 1st 2021, 6:08am |
|
@Tickeron $CYTK enters an Uptrend as Momentum Indicator exceeded the 0 level on July 19, 2021. View odds for this and other i… https://t.co/veWtDBhzuZ August 1st 2021, 6:08am |
|
@TradeWithAlerts Large Print $CYTK Size: 193273 Price: 29.68 Time: 1600 Amount: $5,736,342.64 - Delayed - For real time prints subsc… https://t.co/5qsi1sMlrW July 30th 2021, 8:07pm |
 |
@options__edge $CYTK pulling in the 2020 award for cruelest fake breakout. https://t.co/zYAjC2JbEY July 29th 2021, 11:07pm |
 |
@Achi_Nta $CYTK Alerts, price targets, real traders, live updates, and accountability. More ? @Achi_Nta https://t.co/1CmqOFipcL July 29th 2021, 3:07pm |
 |
@Aleksandr313313 Hello, just to start my first tweet. I had a great trading profits lately. $CYTK is up 50%, $AAPL i got at 122 i… https://t.co/B6jKZagNJG July 29th 2021, 5:07am |
 |
@NorthernTrad3r $CYTK, institutions in heavily at 27.50, who's side are you betting on? I'm long https://t.co/bEsH1hkAe8 July 28th 2021, 6:07pm |
|
@Tickeron $CYTK in Uptrend: RSI indicator stops in overbought zone for 5 days. View odds for this and other indicators:… https://t.co/R3Pev0E14X July 28th 2021, 12:07am |
 |
@john_kro RT @stockhoot: $CYTK - Winning Stocks trade idea by JOHN KROLIKOWSKI JR | 88.22 % return | Better that expected, can't complain #TradeIde… July 27th 2021, 8:07pm |
 |
@ShortAlgoTrades $CYTK I told you ! 5.97% down since our short alert. Trading is easy with UltraAlgo. https://t.co/5IxNWDqfyg July 27th 2021, 2:07pm |
 |
@PaceTrading Whenever $CYTK begins to fill the gap below 26.50, I think it would be a good idea to short/put it. July 27th 2021, 1:07pm |
 |
@ChartMill $CYTK has an average volume of 2044420. This is a good sign as it is always nice to have a liquid stock.… https://t.co/dFJujycBCC July 27th 2021, 10:07am |
|
@Tickeron $CYTK enters an Uptrend because Momentum Indicator exceeded the 0 level on July 19, 2021. View odds for this and ot… https://t.co/0IRYHtYfvh July 27th 2021, 1:07am |
 |
@TortozaLeandro $CYTK And now waiting for Buy signal. https://t.co/E3kUDUxqHI July 26th 2021, 4:07pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?